Skip to main content

Table 2 Demographical and clinical features at non-Hodgkin lymphoma diagnosis

From: The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort study

Variables

Categories

n (%)

Total

 

215

Gender

Male

172 (80.0)

Age (years)

<35

31 (14.4)

35-49

136 (63.3)

≥50

48 (22.3)

 

Mean (SD)

43.2 (9.0)

Period of Diagnosis

1998-2002

71 (33.0)

 

2003-2007

88 (40.9)

 

2008-2012

56 (26.1)

IDU

Yes

96 (42.8)

Migrants

Yes

28 (8.7)

Previous AIDS defining event

Yes

81 (37.7)

HBV or/and HCV co-infection

Yes

111 (51.6)

cART

Yes

172 (80.0)

CD4 cell count, cell/mm3

<200

104 (54.2)

≥200

88 (45.8)

 

Mean (SD)

275.9 (235.3)

CD4/CD8 Ratio

<1

158 (89.3)

≥1

19 (10.7)

 

Mean (SD)

0.46 (0.50)

HIV-RNA, copies/mL

Undetectable

49 (26.1)

Positive

139 (73.9)

 

Mean (SD)*

113208.8 ( 310601.3)

Status at the end of the follow-up

Alive

117 (54.4)

Dead

98 (45.6)

  1. Abbreviations: SD Standard Deviation, IDU Intravenous Drug Use, HBV Hepatitis B Virus, HCV Hepatitis C Virus, cART combined Antiretroviral Therapy, *In subjects with positive HIV-RNA.